OTCQX:MRVFF - Post by User
Post by
GRIFF13on Feb 20, 2010 10:17pm
418 Views
Post# 16803672
DC says it all!
DC says it all!"In 2009, we laid the groundwork for Nuvo to mature into a profitable, diverse, drug development company with a focus on pain-related therapeutics," said Dan Chicoine, Chairman and Co-Chief Executive Officer of Nuvo Research. "We are eagerly anticipating Covidien's launch of Pennsaid in the first half of 2010. We believe that our best-in-class topical NSAID marketed by a partner like Covidien has the potential to generate significant revenue that will allow us to more aggressively invest in our pipeline and build our Company."
Seems to me it's steady as she goes. The sailing should be smoother from here. It will take time for the market to digest the numbers and decide whether Nuvo is to be trusted or not.
I see no need for a reverse split nor is one being hinted at in the release. We will just have to wait and see how the rollout in the US goes. Nuvo has been adrift for a long time. It's time to start swimming for shore.
Ted Warren used to say, "The longer the base, the stronger the case". Definitely accumulation going on here. The question is, by who??
GRIFF